Strategic Partnerships Texas Biomed actively collaborates with global researchers and institutions and has recent partnerships with La Jolla Institute for Immunology, Flyttr, Island Pharmaceuticals, and the U.S. Department of War, indicating strong alignment with external research partners that could be expanded to identify joint grant opportunities, contract research, and technology licensing.

Countermeasure Development The institute focuses on developing medical countermeasures and antiviral compounds against Ebola and other emerging threats, presenting opportunities to offer targeted safety testing, preclinical studies, regulatory consulting, and risk assessment services to government agencies and biotech partners.

Defense & Security Fit With CRADA activity and defense-oriented collaborations, there is a clear foothold for services in biodefense, threat modeling, and rapid-response research programs that can be packaged as funded initiatives or government-sponsored projects.

Global Research Network A broad international collaboration footprint and multiple disease focus areas (viral pathogens, parasitic diseases, metabolic and cardiovascular research) open avenues for multi-site clinical and translational partnerships, technology transfer, and joint grant applications.

Funding & Scale Signals Recognized as a leading independent biomedical research institution with a modest revenue range and 200+ acre campus, presenting opportunities to propose sponsored studies, contract research, and long‑term strategic partnerships that leverage their scale and specialized capabilities.